Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07001059 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound

Study acronym: PETRUS
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Dec 31, 2027 to Mar 31, 2028
    • Start date changed from estimate of Jun 15, 2025 to Sep 4, 2025
    • Site details revised at 9 of 9 sites
    v3
  2. Start date: Jun 1, 2025 to Jun 15, 2025
    • Secondary endpoints: 6 to 8
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate whether the measure of the optic nerve sheath is a reliable diagnostic marker for giant cell arteritis
Trial Details
NCT Number NCT07001059
Lead Sponsor Hôpital NOVO
Conditions
(from sponsor)		 Giant Cell Arteritis (GCA)
Related terms Giant Cell Arteritis
Enrollment 190 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov